Project Details
| Short title | CA244-0012 |
|---|---|
| Acronym | IZABRIGHT-BLADDER01 |
| Status | Active |
| Effective start/end date | 22/09/25 → 21/09/30 |
CTU: IZABRIGHT-BLADDER01: A Randomized, Open-label, Phase 2/3 Trial of Izalontamab Brengitecan Versus Platinum-based Chemotherapy For Metastatic Urothelial Cancer in Participants with Disease Progression On Or After An Immunotherapy-based Treatment
- Zhang, Alison (Primary Chief Investigator)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Lawrie, Angus (Clinical Trial Unit Staff)
- Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)
Project: Research